Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase NA 1Phase 3 1Phase 1/2 1

Status

Terminated 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Breast Neoplasms 9Prostatic Neoplasms 8Neoplasms 5Lung Neoplasms 5Head and Neck Neoplasms 5Leukemia, Myeloid, Acute 4Hematologic Neoplasms 3Colorectal Neoplasms 3Carcinoma, Non-Small-Cell Lung 3Recurrence 2Pulmonary Disease, Chronic Obstructive 2Neoplasm Metastasis 2Lymphoma, Follicular 2Leukemia 2Colonic Neoplasms 2COVID-19 2Xerostomia 1Urologic Neoplasms 1Urologic Diseases 1Urogenital Neoplasms 1Urinary Bladder Neoplasms 1Urinary Bladder Diseases 1Triple Negative Breast Neoplasms 1Teratoma 1Stroke 1Stomatitis 1Squamous Cell Carcinoma of Head and Neck 1Small Cell Lung Carcinoma 1Skin Neoplasms 1Sarcoma 1

Interventions

Fibroblast Growth Factor 7 4Low-Level Light Therapy 3sargramostim 1dusquetide 1avasopasem manganese 1Standard of Care 1Sodium Chloride 1Salts 1Saliva, Artificial 1Radiotherapy 1Mouthwashes 1Glutamine 1Biotene 1Benzydamine 1Anti-Inflammatory Agents 11-phenyl-3,3-dimethyltriazene 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Stomatitis × Standard of Care × Clear all
NCT00574860 2013-09-20

EN3285 for the Prevention or Delay of Oral Mucositis in Patients With Head and Neck Cancer

Endo Pharmaceuticals

Phase 3 Terminated
240 enrolled
Head & Neck

Head and Neck Neoplasms, Stomatitis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡